Keefe Bruyette lowered the firm’s price target on Bain Capital Specialty Finance (BCSF) to $16 from $17 and keeps a Market Perform rating on the shares. Credit quality remains good, but a non-accrual loan held in the joint venture drove most of the net asset value decline, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCSF:
- Bain Capital Specialty Finance price target lowered to $15 from $16 at Wells Fargo
- Bain Capital Specialty Finance Reports Strong Q3 Earnings
- Bain Capital Specialty Finance: Mixed Sentiment in Q3 Earnings Call
- Bain Capital Specialty Finance Announces Q3 Results and Dividend
- Is BCSF a Buy, Before Earnings?